HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhide Kanayama Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

1/2021Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors.
10/2015Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan.
6/2012Effect of total arthroplasty combined with anti-tumor necrosis factor agents in attenuating systemic disease activity in patients with rheumatoid arthritis.
10/2011Anti-tumor necrosis factor therapy in rheumatoid arthritis patients with a history of deep prosthetic joint infection: a report of four cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhide Kanayama Research Topics

Disease

35Rheumatoid Arthritis
08/2023 - 01/2009
2Osteoporosis
01/2023 - 11/2019
2Inflammation (Inflammations)
08/2021 - 08/2009
2Pain (Aches)
06/2012 - 08/2009
2Necrosis
05/2010 - 01/2009
1Postmenopausal Osteoporosis
02/2024
1Wounds and Injuries (Trauma)
12/2022
1Chills
03/2012
1Pneumonia (Pneumonitis)
03/2012
1Fever (Fevers)
03/2012
1Arthralgia (Joint Pain)
03/2012
1Infectious Arthritis (Septic Arthritis)
03/2012
1Venous Thromboembolism
11/2011
1Pulmonary Embolism
11/2011
1Infections
10/2011
1Surgical Wound
05/2010
1Tuberculosis (Tuberculoses)
01/2009

Drug/Important Bio-Agent (IBA)

9Methotrexate (Mexate)FDA LinkGeneric
12/2020 - 03/2012
8Abatacept (Orencia)FDA Link
11/2020 - 01/2014
5tocilizumab (atlizumab)FDA Link
08/2021 - 01/2014
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 10/2011
4Tumor Necrosis Factor InhibitorsIBA
10/2019 - 03/2015
4Infliximab (Remicade)FDA Link
03/2012 - 01/2009
3Antirheumatic Agents (DMARD)IBA
08/2023 - 10/2015
3Adalimumab (Humira)FDA Link
01/2018 - 01/2014
2romosozumabIBA
02/2024 - 01/2023
2Tacrolimus (Prograf)FDA LinkGeneric
03/2023 - 10/2015
2DenosumabFDA Link
01/2023 - 11/2019
2GlucocorticoidsIBA
01/2023 - 07/2021
2baricitinibIBA
08/2021 - 12/2020
2C-Reactive ProteinIBA
08/2021 - 08/2009
2iguratimodIBA
01/2021 - 01/2016
2Proteins (Proteins, Gene)FDA Link
10/2019 - 05/2010
2Etanercept (Enbrel)FDA Link
08/2014 - 05/2010
1Janus Kinase InhibitorsIBA
08/2021
1Prostaglandins AIBA
08/2021
1glucose utilization inhibitor (IGU)IBA
01/2021
1cyclic citrullinated peptideIBA
11/2020
1Rheumatoid FactorIBA
10/2019
1AutoantibodiesIBA
10/2019
1Prednisolone (Predate)FDA LinkGeneric
03/2012
1Sulfasalazine (Azulfidine)FDA LinkGeneric
03/2012
1AlbuminsIBA
05/2010
1Isoniazid (Ftivazide)FDA LinkGeneric
01/2009

Therapy/Procedure

8Therapeutics
03/2023 - 10/2011
3Biological Therapy
10/2019 - 06/2012
2Arthroplasty
09/2012 - 06/2012
2Knee Replacement Arthroplasty (Total Knee Replacement)
11/2011 - 07/2010
1Orthotic Devices (Orthosis)
12/2022
1Replacement Arthroplasty
10/2015
1Contraindications
10/2011
1Aftercare (After-Treatment)
10/2011
1Chemoprevention
01/2009